Delisting riskPopularity #4,804
Foresight Autonomous (ADR) (FRSX)
Stereo vision and cellular collision prediction for autonomous mobility.
$1.17
vs last close−0.02 (−1.68%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | −9 | 12 | 3 | 3 | |
| Research & development | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 9 | 2 | 2 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 | 1 | 0 | 0 |
| General & administrative | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 1 | 1 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −12 | 0 | 0 | 0 |
| Operating income | −4 | −3 | −3 | −3 | −3 | −3 | −3 | −3 | 9 | −12 | −3 | −3 |
| 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | −12 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 |
| Income before tax | −4 | −4 | −2 | −3 | −3 | −3 | −3 | −3 | −3 | −12 | −3 | −3 |
| Net income from continuing operations | −4 | −4 | −2 | −3 | −3 | −3 | −3 | −3 | −3 | −12 | −3 | −3 |
| Net income | −4 | −4 | −2 | −3 | −3 | −3 | −3 | −3 | −3 | −12 | −3 | −3 |
| EPS, basic | −$52.06 | −$132.14 | −$39.64 | −$82.89 | −$86.49 | −$80.49 | −$62.98 | −$56.46 | −$2.30 | −$10.80 | −$1.08 | −$0.91 |
| EPS, diluted | −$52.06 | −$132.14 | −$39.64 | −$82.89 | −$86.49 | −$80.49 | −$62.98 | −$56.46 | −$2.30 | −$10.80 | −$1.08 | −$0.91 |
| Weighted average shares, basic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 |
| Weighted average shares, diluted | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 |
| EBITDA | −4 | −3 | −1 | −3 | −3 | −3 | −3 | −3 | −3 | −12 | −3 | −3 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −4 | −3 | −2 | −3 | −3 | −3 | −3 | −3 | −3 | −12 | −3 | −3 |
